Unavailable
Unavailable
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 11/12/2024 | $111.00 → $110.00 | Equal-Weight → Overweight | Morgan Stanley |
| 11/8/2024 | $107.00 | Neutral → Buy | BofA Securities |
| 11/7/2024 | $109.00 | Hold → Buy | Vertical Research |
| 9/11/2024 | $116.00 → $117.00 | Outperform | Oppenheimer |
| 9/3/2024 | $109.00 → $120.00 | Neutral → Outperform | Mizuho |
| 7/22/2024 | $95.00 → $115.00 | Hold → Buy | Stifel |
| 6/7/2024 | $116.00 | Outperform | Oppenheimer |
| 5/21/2024 | $100.00 | Overweight → Equal-Weight | Morgan Stanley |
New enzymatic solution promises premium textures in fermented dairy and plant-based products, eliminating the need for stabilizers. NEW YORK, Nov. 14, 2024 /PRNewswire/ -- IFF (NYSE:IFF) today announced the launch of TEXSTAR™, an advanced enzymatic texturizing solution poised to revolutionize the texture of both dairy and plant-based fresh fermented products. This innovative enzyme provides the necessary viscosity in fresh fermented products, without the use of added stabilizers. TEXSTAR™ will enable manufacturers to create products with unique textures that feature familiar, consumer-accepted ingredients. Additionally, the enzyme will allow supply chain fluctuations to be managed more effec
IFF (NYSE:IFF) reported financial results for the third quarter ended September 30, 2024. Third Quarter 2024 Consolidated Summary: Reported (GAAP) Adjusted (Non-GAAP)1 Sales Income Before Taxes EPS Operating EBITDA Operating EBITDA Margin EPS ex Amortization $2.9 B $95 M $0.23 $568 M 19.4% $1.04 First Nine Months 2024 Consolidated Summary: Reported (GAAP) Adjusted (Non-GAAP)1 Sales Income Before Taxes EPS Operating EBITDA Operating EBITDA Margin EPS ex Amortization $8.7 B $393 M
Alexandra Carlin and Alex Lee join the Paris-based fine fragrance team, bringing fresh artistic perspectives PARIS, Nov. 4, 2024 /PRNewswire/ -- IFF (NYSE:IFF) proudly welcomes Alexandra Carlin as Senior Fine Fragrance Perfumer and Alex Lee as Fine Fragrance Perfumer to its Paris-based team. These strategic additions aim to enhance the Company's creative prowess in the world of perfumery. "We're excited for the talent and creative energy that Alexandra and Alex will bring to IFF Scent," said Sabrya Meflah, president, Fine Fragrance, IFF. "Alexandra's ability to translate deep
Stifel analyst Mark S. Astrachan upgraded International Flavors & Fragrances Inc. (NYSE:IFF) stock to Buy from Hold with an increased price target of $115 from $95. The analyst sees 2024 guidance as conservative and is increasing the sales and adjusted EBITDA forecasts for 2024-2025 by 1.5% and 4.4% above the company’s top-end targets. IFF’s volumes rebounded strongly in the first-quarter 2024, rising mid-single-digits after five quarters of decline, writes the analyst. Also Read: IFF’s Focus On Health And Environment Set To Drive Stock Momentum, Says Analyst Astrachan expects mid-single-digit volume growth throughout 2024, driven by improved comparisons and a return to growth am
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. Goldman Sachs cut the price target for Lennar Corporation (NYSE:LEN) from $180 to $174. Goldman Sachs analyst Susan Maklari downgraded the stock from Buy to Neutral. Lennar shares gained 0.5% to close at $170.94 on Friday. See how other analysts view this stock. Piper Sandler increased the price target for NVIDIA Corporation (NASDAQ:NVDA) from $120 to $140. Piper Sandler analyst Harsh Kumar maintained an Overweight rating. NVIDIA shares fell 2.6% to close at $117.93 on Friday. See how other analyst
Intl Flavors & Fragrances (NYSE:IFF) underwent analysis by 14 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish. The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 3 4 7 0 0 Last 30D 1 0 0 0 0 1M Ago 1 0 2 0 0 2M Ago 0 1 0 0 0 3M Ago 1 3 5 0 0 Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $104.5, with a high estimate of $116.00 and a low estimate of $93.00. Observing a 11.35% increase, the current av
144 - INTERNATIONAL FLAVORS & FRAGRANCES INC (0000051253) (Subject)
10-Q - INTERNATIONAL FLAVORS & FRAGRANCES INC (0000051253) (Filer)
8-K - INTERNATIONAL FLAVORS & FRAGRANCES INC (0000051253) (Filer)
4 - INTERNATIONAL FLAVORS & FRAGRANCES INC (0000051253) (Issuer)
4 - INTERNATIONAL FLAVORS & FRAGRANCES INC (0000051253) (Issuer)
4 - INTERNATIONAL FLAVORS & FRAGRANCES INC (0000051253) (Issuer)
Morgan Stanley upgraded Intl Flavors from Equal-Weight to Overweight and set a new price target of $110.00 from $111.00 previously
BofA Securities upgraded Intl Flavors from Neutral to Buy and set a new price target of $107.00
Vertical Research upgraded Intl Flavors from Hold to Buy and set a new price target of $109.00
SC 13G/A - INTERNATIONAL FLAVORS & FRAGRANCES INC (0000051253) (Subject)
SC 13G/A - INTERNATIONAL FLAVORS & FRAGRANCES INC (0000051253) (Subject)
SC 13G - INTERNATIONAL FLAVORS & FRAGRANCES INC (0000051253) (Subject)
IFF (NYSE:IFF) reported financial results for the third quarter ended September 30, 2024. Third Quarter 2024 Consolidated Summary: Reported (GAAP) Adjusted (Non-GAAP)1 Sales Income Before Taxes EPS Operating EBITDA Operating EBITDA Margin EPS ex Amortization $2.9 B $95 M $0.23 $568 M 19.4% $1.04 First Nine Months 2024 Consolidated Summary: Reported (GAAP) Adjusted (Non-GAAP)1 Sales Income Before Taxes EPS Operating EBITDA Operating EBITDA Margin EPS ex Amortization $8.7 B $393 M
IFF (NYSE:IFF) announced that its Board of Directors has declared a regular quarterly cash dividend of $0.40 per share of its common stock, payable on January 8, 2025 to shareholders of record as of December 20, 2024. Welcome to IFF At IFF (NYSE:IFF), an industry leader in food, beverage, scent, health and biosciences, science and creativity meet to create essential solutions for a better world – from global icons to unexpected innovations and experiences. With the beauty of art and the precision of science, we are an international collective of thinkers who partners with customers to bring scents, tastes, experiences, ingredients and solutions for products the world craves. Together, we
IFF (NYSE:IFF) today announced that it will release its third quarter 2024 earnings results following the market close on Tuesday, Nov. 5, 2024. The management team will host a live webcast on Wednesday, Nov. 6, 2024 at 9:00 a.m. ET to discuss results and outlook with the investor community. Investors may access the live webcast and accompanying slide presentation on the Company's website at ir.iff.com. For those unable to listen to the live webcast, a recorded version will be made available for replay. Welcome to IFF At IFF (NYSE:IFF), an industry leader in food, beverage, health, biosciences and scent, science and creativity meet to create essential solutions for a better world – from g
Alexandra Carlin and Alex Lee join the Paris-based fine fragrance team, bringing fresh artistic perspectives PARIS, Nov. 4, 2024 /PRNewswire/ -- IFF (NYSE:IFF) proudly welcomes Alexandra Carlin as Senior Fine Fragrance Perfumer and Alex Lee as Fine Fragrance Perfumer to its Paris-based team. These strategic additions aim to enhance the Company's creative prowess in the world of perfumery. "We're excited for the talent and creative energy that Alexandra and Alex will bring to IFF Scent," said Sabrya Meflah, president, Fine Fragrance, IFF. "Alexandra's ability to translate deep
NEW YORK, Sept. 26, 2024 /PRNewswire/ -- IFF (NYSE:IFF) Pharma Solutions is proud to announce its more than 75-year legacy as an excipient manufacturer with new product launches and technologies for the pharmaceutical and biotech industries. Celebrating this pivotal milestone, IFF will spotlight its latest solutions for nitrosamine mitigation at CPHI 2024, Milan, Oct. 8-10, booth 6B10. The range includes a new portfolio of low nitrite excipients and ultrapure alginate biopolymers for next-generation therapeutic development. "We are unveiling groundbreaking technologies that re
IFF (NYSE:IFF) today announced the appointment of Margarita Paláu-Hernández to its Board of Directors, effective June 3, 2024. Paláu-Hernández joins as a mutually agreed independent Director in connection with IFF's previously disclosed cooperation agreement with Icahn Capital LP and its affiliates. Following the appointment of Paláu-Hernández, the Board will be comprised of 11 members, ten of which are independent. "We are pleased to welcome Maggie to the IFF Board," said Roger Ferguson, lead director of IFF. "Her legal expertise, consumer insights, and her experience in emerging markets will be invaluable to IFF as we continue to execute on our growth and transformation plan to drive in